Page 48 - Sohini Das

Indian pharma R&D spends stay stagnant three years after pandemic downturn

Spends are now lower relative to sales than before Covid-19, stand at 4.4% of net sales, compared with 20% in the US

Have to keep R&D spends at 12% of revenue: Biocon's Kiran Mazumdar-Shaw

It's a high growth phase for us in Biocon Biologics: We crossed the Rs 1,500-crore mark in revenue for the first time this quarter. We will exit this year (FY23) at Rs 2,000-crore level

Supply chains back to pre-Covid levels for consumer durable firms

Constraints still easing for auto firms; companies wary of commodity prices as Chinese demand may push them up

Viatris deal-related expenses drag Biocon's Q3 net into Rs 42 cr loss

This, even as revenues rise 36% and Ebitda is up 35%

How AI is changing the diagnostic landscape, slowly but steadily

Med-tech companies are working round the clock to come up with AI-based solutions

Audi India to start making the Q3 range in India this calendar year

At present, the firm imports these cars as fully built-up units that attract 110% duty; local manufacturing would help reduce wait periods and boost sales

Semiconductor chip supply constraints put brakes on auto OEM ramp-up

Firms struggle to increase production as supplies yet to fully normalise

India's drug regulator serves show-cause notice to online pharmacies

Gives firms two days to respond to allegations that they flouted rules

M&M Q3 results: PAT rises 14% to Rs 1,528 crore; revenue jumps 41%

M&M will now focus on growing farm machinery revenues by 10-fold in next 5 years

Skoda making in India for the world, says MD & CEO Piyush Arora

'We are looking at 2023 with great expectations. Our aim is to score double-digit growth'

Manipal Health Enterprises, Emami Group break logjam on AMRI Hospitals

Reportedly, Max Healthcare had entered the fray for AMRI Hospitals, offering a better bid than Manipal Health's Rs 1,800-crore offer for AMRI

With focus on non-US geographies, Amneal Pharma eyes India market

The company is actively recruiting its field force, and aims to have 600-700 medical representatives by the end of 2023

Online medical consultations in smaller cities grew 87% last calendar year

Lybrate study reports 65% spike in online appointments by women in 2022 over 2021; gastroenterology and ENT top list of consulted specialities

Centre plans to roll out research-linked incentive scheme for pharma sector

In the Union Budget 2023-24, Finance Minister Nirmala Sitharaman had hinted at fostering a research-driven climate in the pharma sector in India

Regulators halt eye products' production at Global Pharma Healthcare site

Firm under US FDA scanner for bacterial contamination of its eye drops

Chennai-based firm's eye drops contaminated, says US FDA report

The US FDA said that using contaminated artificial tears increases risk of eye infections that could result in blindness or death

Disallowing input tax credit may increase CSR cost, impact beneficiaries

CSR activities were not treated as a business expenditure

Duty hike won't apply brakes on luxury car demand, say automakers

For mass segment cars priced above Rs 35 lakh, move can lead to more localisation

Business initiative that has a heart: Lupin eyes Lyfe beyond the pill

Its digital health initiative for cardiac patients is part of its strategy to diversify into healthcare services

Govt health spend must hit 2.5% of GDP by 2025, says Economic Survey

At the same time, out-of-pocket expenditure as a percentage of total health expenditure has declined from 64.2 per cent in FY14 to 48.2 per cent in FY19